The free online event will connect cancer
patients and caregivers with the latest promising research findings
shared by top immunotherapy experts, patient success stories, and
clinical trial updates, on September 22,
2022, at 2 p.m. ET

NEW
YORK, Sept. 6, 2022 /PRNewswire/ — The Cancer
Research Institute (CRI), a nonprofit organization spearheading
transformative research to harness the immune system’s power to
control and potentially cure all cancers, will offer its second
annual CRI Virtual Immunotherapy Patient Summit in Spanish on
September 22, 2022, 2-5 p.m. ET. This free virtual event, moderated
by TV Host and Entrepreneur Ana Patricia Gámez, and presented
completely in Spanish, will connect Hispanic cancer patients and
caregivers with groundbreaking research updates from leading
immunotherapy experts driving scientific breakthroughs and
advancements that impact patient care.  

According to the Center for Disease Control (CDC), cancer is the
leading cause of death among Hispanic people, with current cancer
research and statistics indicating a higher incidence of liver
cancer, stomach cancer, and cervical cancers in the Hispanic
population. With harrowing statistics like, 1 in 3 Hispanic men
and women will be diagnosed with cancer in their lifetime, and 1 in
5 men and 1 in 7 women will die from the disease¹,
 CRI continues its commitment to empower the U.S. Hispanic
cancer community and help create a world immune to
cancer. 

Cancer immunotherapy is a form of cancer treatment that uses the
body’s own immune system to control and eliminate cancer. CRI is
bringing the promise of immunotherapy to the underserved
Spanish-speaking U.S. Hispanic community with in-language research,
information, and direct access to clinical trials, to ultimately
improve treatment outcomes for this patient group. CRI offers free
clinical trial consultations where a professional will walk
patients and their families through their immunotherapy clinical
trial options. In addition, CRI will be developing content and news
bites in Spanish from leading members of the CRI scientist
community, sharing Hispanic-relevant information and patient
stories. 

“Understanding a cancer diagnosis and treatment options are a
vital part of a patient success story, said Dr. Kurt Schalper,
associate professor of pathology and medicine (medical oncology),
Yale School of Medicine, director of
the Translational Immuno-Oncology Laboratory, Yale Cancer Center,
and CRI Virtual Immunotherapy Patient Summit keynote speaker.
“There is an undeniable need to make information available
in-language for Spanish-speaking cancer patients and caregivers.
Knowledge and access to data are key components for patients to
advocate for themselves and make informed choices. I am honored to
be a part of CRI’s second annual Cancer Immunotherapy Summit to
help benefit the U.S. Hispanic cancer community.” 

An early diagnosis can make the difference between life and
death, and overall Hispanic men and women are generally less likely
to be diagnosed at an early stage, when treatment is usually less
intensive and more successful. Over the past two years, the Cancer
Research Institute has launched several initiatives to engage
Spanish-speaking Hispanic patient and caregiver communities
including the development of an immunotherapy patient information
hub in Spanish we well as the first all-Spanish language CRI
Virtual Immunotherapy Patient Summit, which included an informative
session devoted to overcoming racial and ethnic inequalities in
access to health information and care. 

“Here at the Cancer Research Institute, we continue to work to
address barriers that hinder scientific progress and access to
Spanish-language health information and care by creating a platform
for scientists and patients to share their firsthand experiences at
the forefront of cancer immunotherapy research and connect with
clinical trials,” said Jill
O’Donnell-Tormey, Ph.D., CEO and director of scientific
affairs at CRI. “We hope to reach and positively impact the U.S.
Hispanic cancer community via our in-language CRI Virtual
Immunotherapy Patient Summit, and with the integral participation
of our media sponsor TelevisaUnivision and host Ana Patricia
Gámez.

“I am so very honored to be asked back to moderate the second
annual CRI Virtual Immunotherapy Patient Summit in Spanish,” said
Ana Patricia Gámez, TV host and entrepreneur. “It is a privilege to
support Hispanic cancer patients and caregivers in their healthcare
journey once again, connecting the community with potentially
lifesaving information and access to clinical trials. I do this in
loving memory of my father, and I know he would be proud to be a
part of such an important program.” 

“As a journalist, it is my duty to serve my community, and I am
deeply grateful for the opportunity to moderate a panel and be a
part of the CRI mission to better serve U.S. Hispanic cancer
patients and caregivers,” said Teresa Rodríguez, host of
Univisionarios (Univision News). 
“There is a need to engage and help our community overcome barriers
to better care and treatments.” 

From the comfort and safety of home, attendees of the free CRI
Virtual Immunotherapy Patient Summit in Spanish can expect to:

• Learn the basics of cancer immunotherapy and how it may
  help them or their loved one.
• Hear from and interact with leading physician-scientists
  with expertise in cancer immunotherapy.
• Gain valuable insight into how clinical trials work and
  to understand whether they are a good option for patients to
  explore with their healthcare team.
• Learn more about the latest research on cancers most
  affecting the U.S. Hispanic community.
• Discover issues specific to U.S. Hispanic communities
  regarding overall health care and how doctors, organizations,
  advocates, and individuals are addressing these challenges.
• Hear real patients who have undergone immunotherapy
  treatment tell their story.

Support for the Spanish-language 2022 CRI Virtual Immunotherapy
Patient Summit is generously provided by the following
sponsors:

Official Media Sponsor: TelevisaUnivision

• Gold: 
• Silver: 
• Contributor:
• • Regeneron Pharmaceuticals, Inc.
  • Sanofi
• Friend:
• • Eli Lilly and Company
  • Genmab
  • MorphoSys 
• Host Institutions
• • Dana-Farber Cancer Institute
  • NYU Langone Health
  • University of Chicago Comprehensive
    Cancer Center
  • Univeristy of Texas MD Anderson Cancer Center
  • Yale Cancer Center and Smilow Cancer Hospital

The Cancer Research Institute has pledged to help close the
information and research gap and better serve the Spanish-speaking
U.S. Hispanic community. Visit cancerresearch.org/es to see the
robust and helpful offering of information now available in
Spanish. Visit cancerresearch.org/es/conferencia to register
for the free Spanish-language 2022 CRI Virtual Immunotherapy
Patient Summit.

About the Cancer Research Institute 
The Cancer Research Institute (CRI), established in 1953, is a
top‐rated U.S. nonprofit organization dedicated exclusively to
saving more lives by fueling the discovery and development of
powerful immunotherapies for all cancers. Guided by a
world‐renowned Scientific Advisory Council that includes four Nobel
laureates and 27 members of the National Academy of Sciences, CRI
has invested $500 million in support
of research conducted by immunologists and tumor immunologists at
the world’s leading medical centers and universities and has
contributed to many of the key scientific advances that demonstrate
the potential for immunotherapy to change the face of cancer
treatment. To learn more, go to cancerresearch.org/es.

¹ American Cancer Society.
Cancer Facts & Figures for Hispanic/Latino People
2021-2023. Atlanta: American
Cancer Society, Inc. 2021.

View original content to download
multimedia:https://www.prnewswire.com/news-releases/cancer-research-institute-to-host-second-annual-spanish-language-virtual-immunotherapy-patient-summit-moderated-by-ana-patricia-gamez-to-connect-the-us-hispanic-cancer-community-with-information-that-can-save-lives-301618148.html

SOURCE Cancer Research Institute